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OBJECTIVES The aim of our study was to analyze the cellular components of neointimal tissue regeneration
after coronary stenting.
BACKGROUND High restenosis rates are a major limiting factor of coronary stenting. To reduce the
occurrence of restenoses, more insights into the mechanisms leading to proliferation and
expression of extracellular matrix are necessary.
METHODS Twenty-one autopsy cases with coronary stents implanted 25 h to 340 days before death were
studied. The stented vessel segments were analyzed postmortem by light microscopy and
immunohistochemical staining.
RESULTS In the initial phase stents are covered by a thin multilayered thrombus. Alpha-actin–positive
smooth muscle cells (SMCs) are found as the main cellular component of the neointimal
tissue. Later (.6 weeks) extracellular matrix increases and fewer SMCs can be found. In every
phase the SMC layers are loosely infiltrated by inflammatory cells (T lymphocytes). In the
early postinterventional phase all endothelial cells are destroyed. The borderline between the
vessel lumen and the vascular wall is constituted by a thin, membranous thrombus. Six weeks
after stenting, SMCs form the vessel surface. Complete reendothelialization is first found 12
weeks after stenting.
CONCLUSIONS Stent integration is a multifactorally triggered process with proliferating SMCs generating
regenerative tissue. In the early phase predominantly thrombotic material can be observed at
the site of stenting, followed by the invasion of SMCs, T lymphocytes and macrophages. The
incidence of delayed reendothelializations and the occurrence of deep dissections may be
associated with excessive SMC hyperplasia. (J Am Coll Cardiol 2000;35:157–63) © 1999 by
the American College of Cardiology
Progressive optimization of implantation techniques involv-
ing minimally invasive endoprosthesis therapies (stenting)
and modification of the medical regimen have helped to
reduce early complication rates after coronary stenting (1).
Higher expansion pressures and improved medical regimens
like the use of ticlopidine, aspirin, clopidogrel and glyco-
protein IIb/IIIa receptor inhibitors resulted in a reduction of
early complication rates after coronary stenting (2–4). In
contrast, the occurrence of in-stent restenosis still remains
an unsolved issue. Aside from a rather high incidence of
in-stent restenosis within the first months after stenting,
one of the major limitations is related to the treatment
options (5). After coronary stenting, restenosis rates from
20% to 50% are found. A significant reduction of lumen
cross-sectional area is found more often in long coronary
stenoses. Highest restenosis rates have to be expected after
multiple, overlapping stent insertion or after stenting of
small coronary vessels with diameters ,3 mm (6,7).
Analysis of the mechanism of stent integration by intra-
vascular ultrasound (IVUS) has demonstrated that stent
compression does not contribute to restenosis (8,9). So far
there is no evidence for a proliferating and regenerating
process of all parts of the vessel wall (remodeling) as a major
component of restenosis (10). Animal studies using IVUS
and histomorphologic analysis of neointimal material ex-
cised from humans have shown that a focally accentuated
intimal tissue response occurs after stent implantation. This
tissue response is caused by migration and excessive prolif-
eration of smooth muscle cells (SMCs) (11–14). Because
tissue identification and characterization is not possible
using IVUS, animal studies were designed to define the
histologic tissue response (neointima) after stenting (13,15).
The application of data from currently available animal
models to the human restenosis mechanism after stent
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implantation is limited by species-specific tissue reactions.
Considering these species-specific differences and the im-
plantation into undiseased artery segments, animal studies
might differ considerably from studies of human arterioscle-
rotic arteries.
The aim of our study was to characterize the histologic
and immunohistochemical cellular and matrix interactions
between human vascular walls and coronary stents.
METHODS
The tissue response to 31 stainless-steel coronary stents of
21 patients 25 h to 340 days after implantation was analyzed
postmortem. The stented segments were identified by
coronary angiography of the isolated hearts after death.
Postmortem analysis was performed in the first 24 h after
death. After 72-h, 5% formalin pressure fixation of the
dissected coronary artery, the stented segment was cut into
halves. The two parts of the stent were prepared in different
ways. The first half was plastic-embedded into methyl-
methacrylate (Technovit 9100, Kulzer, Germany), and cross
sections were produced using the hardcut-grinding tech-
nique (Accutom 5000, Wirtz-Bu¨hler, Germany). By apply-
ing this method of preparation using a rotating hardcut
microtome, serial cross sections (interspace 0.3 mm) were
obtained. Automated precision polishing (Pho¨nix, Wirtz-
Bu¨hler, Germany) to a thickness of 10 mm per cross section
was performed (complete details of the methods will be
provided by the authors upon request). Artifact-free samples
are available for staining (modified Ladewig staining) and
microscopic analysis. Quantitative analysis was performed
using our computer-based video morphometry unit
(VIDAS-Video, Zeiss, Germany). After excision of the
metal struts, the second half of the stent region was
processed for immunohistochemical staining. Immunohis-
tochemical staining with alpha1 actin, factor VIII, cluster of
differentiation (CD)3, CD21 and CD68 was performed
under standard conditions. Immunohistochemical charac-
terization of the inflammatory cells was possible only in
stents already incorporated by neointima (n 5 12). Table 1
shows the patient characteristics of the analyzed cases.
RESULTS
Histopathologic Study and Light Microscopy
Light microscopy and video-based morphometry of the
stented cross sections revealed inhomogeneous stent expan-
sion in eccentric and concentric arteriosclerotic stenoses.
The stents were underexpanded over calcified arterioscle-
rotic segments of the vessel wall and, in these parts, did not
contribute to the initial lumen gain. In parts of the vascular
segments with elastic fibrous arteriosclerotic disease, over-
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CD 5 cluster of differentiation
IVUS 5 intravascular ultrasound
L-316 5 chromium-nickel-ferrum stainless steel
SMC 5 smooth muscle cell















10/95 F 70 95 d Ex. card. 1 1 LAD Palmaz-Schatz
30/95 M 56 32 h Cardiac 2 2 LAD Palmaz-Schatz (3 stents)
38/95 M 71 61 d Ex. card. 2 1 LAD Palmaz-Schatz
122/95 M 67 28 d Ex. card. 2 1 LAD DEVON
243/95 M 54 12 d Cardiac 2 2 LAD MICRO (2 stents)
382/95 M 64 10 d Cardiac 2 2 LAD MICRO
291/96 M 70 96 d Ex. card. 1 1 Bypass DEVON (2 stents)
291/96 M 70 124 d Ex. card. 1 1 Bypass DEVON
365/96 M 76 11 d Ex. card. 2 2 LAD Multi-Link
31/97 F 81 9 d Cardiac 2 2 RCA NIR Cordis (3 stents)
53/97 F 73 150 d Cardiac 1 1 LCx Palmaz-Schatz
103/97 F 65 311 d Cardiac 1 1 LAD NIR Cordis
123/97 M 74 40 d Cardiac 2 1 RCA DEVON
174/97 M 78 90 d Ex. card. 1 1 LAD MICRO
324/97 M 71 30 d Cardiac 2 1 LAD NIR
324/97 M 71 101 d Cardiac 1 1 LCx Roubin
929/98 M 38 340 d Cardiac 1 1 LAD Palmaz-Schatz
68/98 M 65 25 h Cardiac 2 2 RCA NIR Cordis (2 stents)
154/98 M 68 48 h Cardiac 2 2 RCA DEVON
223/98 F 76 229 d Cardiac 1 1 RCA Roubin (2 stents)
223/98 F 76 118 d Cardiac 1 1 LAD Palmaz-Schatz (3 stents)
Ex. card. 5 extracardiac; F 5 female; LAD 5 left anterior descending coronary artery; LCx 5 left circumflex coronary artery; M 5 male; RCA 5 right coronary artery.
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expansion of the endoprosthesis could be seen leading to
deep impression of the stent filaments into the soft plaques.
A gain in stent symmetry by high pressure stenting was not
found (Fig. 1A).
With intraindividual differences, the generation of the
stent neointima can be divided into two different time
phases (Table 2). The regeneration of the endothelial border
seems to occur in three different time phases (Table 3).
Phase I of Neointimal Generation: Reparation
Eleven to 16 days after stenting only incomplete tissue
coverage of the endoprosthesis (Fig. 1B) was documented.
Complete coating of the stents was first found 28 days after
stent implantation. This early neointima contains almost no
matrix structures. It consists of a basis of thrombotic
material with incorporated red blood cells, aggregated
thrombocytes and neutrophil granulocytes. Four weeks after
stenting a focal augmentation of extracellular matrix is
observed in those parts of the vascular wall compressed by
stent struts. In this early phase, lymphocytes as a major part
of an inflammatory response are accentuated in neointimal
segments directly adjacent to the stent struts, but they can
Figure 1. A, Light microscopic specimen (subject no. 243/95). Histologic cross section of a stented coronary artery. Implantation pressures
of 15 atm did not produce complete stent expansion. Subacute stent thrombosis after 12 days. Lumen obstructed by thrombotic material
(th). Extensive calcification (ca) impeding complete homogeneous stent expansion. S 5 stent strut. (Magnification 311, reduced by 65%.)
B, Gross specimen (subject no. 365/96). Longitudinally dissected coronary artery 11 days after stenting. The endoprosthesis is
incompletely covered by a thin, membranous thrombus 3. In between stent filaments multiple intramural hematomas can be identified.
(Magnification 37.) C, Light microscopic specimen (subject no. 122/95) of a histologic cross section of a coronary artery 28 days after
stenting. Stent struts (S) show coating by neointima (n) with few cellular infiltrates. The borderline between neointima and arteriosclerotic
plaque (p) is still visible. Lumen (l) filled with contrast medium after postmortem coronary angiography. m 5 media; a 5 adventitia.
(Magnification 325, reduced by 65%.) D, Gross specimen (subject no. 291/96). Longitudinal section of a coronary artery six months after
stent implantation. Stent struts (S) covered by gray neointima. Intercellular hemosiderin pigments as residuals of intramural bleedings (b)
caused by the implantation trauma in the outer media. l 5 lumen. (Magnification 38.5, reduced by 65%.)
Table 2. Phases I and II of Neointimal Generation
I. Phase of Reparation
Intramural hematoma after intimal plaque rupture or
dissection of the media
Generation of a membranous mural thrombus (including
red blood cells, neutrophils, aggregations of
thrombocytes)
Loosely structured matrix components
II. Phase of Proliferation
Initial increase of SMCs
Progressive solidification of matrix structure
Loose infiltration by lymphocytes
Lymphocytic aggregation around stent struts
Matrix cover around stent struts without SMCs
SMCs 5 smooth muscle cells.
Table 3. Phases I–III of Endothelial Regeneration
I. Phase: Endothelial Denudation
Destruction of the endothelial vessel wall lining in the
implantation zone
II. Phase: Reendothelialization
Neointimal surface covered by matrix and SMCs
Spots of neoendothelium
III. Phase: Neoendothelium
Complete coverage by factor VIII–positive cells of
endothelial origin
SMCs 5 smooth muscle cells.
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be found uniformly distributed over the complete stented
artery segment.
In between stent struts, the neointimal tissue measures up
to 120 mm from the arterial media to the lumen. At points
over the stent filaments the neointima measures only a few
micrometers (Fig. 1C).
Phase II of Neointimal Generation: Proliferation
Over the time course of incorporation, a decrease in inflam-
matory infiltration and an increase of SMC and extracellular
matrix was documented. Higher numbers of SMCs went
along with increasing neointimal volume. The effects of the
implantation trauma were still visible nine months after
stenting—large, only partially organized intramural hema-
tomas (Fig. 1D). The thickness of the neointima was found
to be between 110 mm 40 days after and 450 mm 321 days
after stent incorporation.
Immunohistochemical Analysis
Neointima. Twenty-eight days after stent implantation
some alpha-actin–positive cells (SMCs) start to migrate into
the arterial wall. These cells are embedded into a loose
extracellular matrix with only a few fiber bundles. An
increase of more concentric, circular-aligned tissue is found
over the time course after stenting. By testing alpha-actin, a
focally accentuated accumulation of SMCs was seen in the
neointima in all cases (Fig. 2A).
More than 12 weeks after stenting, the neointima consists
of a three-layered tissue with intra-individual differences:
1) Alpha-actin–positive cells are located in the luminal area
of the neointima. The alpha-actin–positive SMCs are
circular-aligned and interposed onion-like. This layer
consists of 15 to 30 cell layers.
2) The adjacent, middle layer appears less cellular. Only a
few SMCs are embedded into a thick layer of intercel-
lular matrix. There is almost no cellular interdigitation in
between the alpha-actin–positive cells.
3) The outer part of the neointima becomes more cellular
.3 months after stenting, building a thick cellular
stratum. This layer continuously extends into the origi-
nal medial lamina of the vascular wall or into the SMC
cover found in plaque caps of arteriosclerotic lesions.
The tissue response after stenting usually produced con-
centric narrowing of the lumen. A focally accentuated
increase in neointimal thickness was based on intramural
bleeding. These hematomas are found to be in different
phases of organization.
Arteriosclerotic plaques proximal and distal to the stented
segments show different vessel wall structures than the stent
neointima. Smooth muscle cells are accumulated in the
surface near plaque cap. The central lipid-rich plaque zone
is dominated by cholesterol crystals and CD68-positive
macrophages with only a few alpha-actin–positive cells
(SMCs).
Figure 2. A, Immunohistochemical staining (alpha-actin). Neointima 101 days after stenting (subject no. 324/97). Compact layer of
alpha-actin testing positive cells (red) in the luminal zone of the intima. Loose infiltration with alpha-actin–positive cells of the intercellular
matrix in the thicker, outer layer of the neointima. (Magnification 345, reduced by 65%.) B, Light microscopic specimen. Stent neointima
after removal of the stent struts (s) (subject no. 174/97). Directly adjacent to the alloplastic stent filaments no alpha-actin–positive SMCs
(red) can be detected. (Magnification 345, reduced by 65%.) C, Immunohistochemical staining after removal of stent struts (subject no.
38/95). Factor 8-negative cells form the borderline between the lumen (l) and neointima (n) 68 days after stenting. Endothelial cells of
the hyperemic vasa vasorum (v) are tested factor 8–positive. Indentation of stent struts. (Magnification 335, reduced by 65%.) D,
Immunohistochemical staining (factor 8-positive 5 red). Complete endothelialization of the neointima by mature endothelial cells 101
days after stenting (subject no. 324/97). Upper, lumen; lower, neointima (distal stent). (Magnification 375, reduced by 65%.)
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Inflammatory response. In addition to alpha-actin–
positive SMCs up to nine months after stenting, increasing
CD3-positive (Fig. 3A) and CD20-negative T lymphocytes
(Fig. 3B) and CD68-positive cells of the monocyte–
macrophage system are found. Later phases of stent incor-
poration show diffuse infiltration of CD3-positive and
CD20-negative T lymphocytes in the neointima (Fig. 3, C
and D). Directly adjacent to the alloplastic stent filaments
are some multinucleated giant cells. CD68-positive macro-
phages accumulate in the intramural bleeding zones near
intimal dissections. CD3-positive T lymphocyte aggrega-
tion is limited to the neointimal zone only. Proximal and
distal artery segments show no infiltration by lymphocytes
(Fig. 3, E and F). Immunohistochemical staining (CD20)
revealed no B lymphocytes in the neointima. In the direct
neighborhood of the alloplastic stent filaments only rare
alpha-actin–positive SMCs were detected. The alloplastic
stent filaments were separated from cellular components by
a thin, acellular fiber-tissue zone (Fig. 2B). No foreign body
granuloma was detected in the study group.
Neoendothelium. PHASE I: ENDOTHELIAL DENUDATION.
Positive cells of endothelial origin tested by factor VIII are
not found on the luminal surface of the neointima in the
early phase of stent integration.
Figure 3. A, Immunohistochemical staining (CD3-positive 5 red). Neointima 96 days after stenting (subject no. 291/96). CD3-positive
T lymphocytes aggregated around the stent struts. Impression of a removed stent filament in the lower right of the figure. Magnification:
CD3-positive cells. s 5 stent strut. (Magnification 335, reduced by 65%.) B, Immunohistochemical staining (CD20-positive 5 red).
Neointima 96 days after stenting (subject no. 291/96). No CD20-positive B lymphocytes in the stent neointima. s 5 stent strut.
(Magnification 335, reduced by 65%.) C, Immunohistochemical staining (CD3-positive 5 red). Neointima 124 days after stenting.
Diffuse infiltration by CD3-positive T lymphocytes in this phase of stent integration. s 5 stent strut. (Magnification 335, reduced by
65%.) D, Immunohistochemical staining (CD20-positive 5 red). Neointima 124 days after stenting (subject no. 291/96). No
CD20-positive B lymphocytes in the stent neointima. s 5 stent strut. (Magnification 335, reduced by 65%.) E, Immunohistochemical
staining (CD3-positive 5 red). No CD3-positive T lymphocytes in the vessel segment 2 cm proximal to the stent (subject no. 291/96).
(Magnification 345, reduced by 65%.) F, Immunohistochemical staining (CD20-positive 5 red). No CD20-positive B lymphocytes in
the vessel segment 2 cm proximal to the implanted stent (subject no. 291/96). (Magnification 345, reduced by 65%.)
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PHASE II: REENDOTHELIALIZATION. Even six weeks after
stenting, the luminal border is not covered by mature factor
VIII–positive endothelium (Fig. 2C). Alpha-actin–positive
SMCs are reaching up to the luminal surface of the
neointima, constituting the borderline between the neoin-
tima and lumen in this reparative phase.
PHASE III: NEOENDOTHELIUM. Complete coverage of the
neointima by factor VIII–positive endothelial cells (neoendo-
thelialization) is first found 96 days after stenting (Fig. 2D).
DISCUSSION
The major in vitro and in vivo studies available demonstrate
a response to injury of the coronary vessel wall after
conventional balloon angioplasty (percutaneous translumi-
nal coronary angioplasty). During this neointimal repair
initially proliferation and migration of SMCs, as well as
expression of intracellular matrix and a later phase of
inflammatory response with cell invasions like macrophages
and lymphocytes, can be demonstrated (16,17).
The inflammatory response after implantation of coro-
nary stents has been shown previously (15,18,19). In addi-
tion, it has been shown that especially the area around the
stent struts shows an increased number of proliferating
SMCs as well as infiltration of macrophages and leukocytes
(18,20). During the six months after stent implantation a
definite tissue response might lead to a reduction of the
lumen size in certain areas due to increased intimal prolif-
eration. Finally the stents are integrated in a proliferating
tissue called “neointima,” leading to incorporation and
neutralization of the alloplastic stent material. In the first six
months after stenting, a hyperproliferative tissue response
may occur, producing continuous narrowing of the lumen
cross-sectional area and diminishing the early luminal gain
after interventional therapy. In clinical angiographic and
IVUS studies, restenosis rates (,50% of the initial reference
diameter) of 32% are documented (5). In 10% to 15% of the
patients target lesion revascularization procedures are
needed to treat in-stent restenosis (21). Proliferating endo-
thelial cells do not contribute to neointima generation, as
documented in pathologic-anatomic case reports on human
atherectomy material (18,22).
Neointima. In accordance with the description of 11 hu-
man probes after stenting by Komatsu et al. (20) and in
congruence with animal studies (12,13), the main compo-
nent of the neointima is alpha-actin–positive SMCs.
Our findings propose two time phases with different
morphologic stages of neointima generation. The first
reparative phase is characterized by coverage of the implan-
tation zone by a thin, membranous thrombus. Over the time
course of incorporation this thrombus is infiltrated by
SMCs secreting extracellular matrix.
In the second proliferative phase increasing numbers of
SMCs and matrix lead to a volume gain of neointima. In
this second phase the neointimal tissue shows a three-
layered structure.
In none of the studied cases were the alpha-actin–positive
SMCs found directly neighboring stent struts. In every
phase of incorporation the alloplastic material is completely
surrounded by an up to 40-mm-thick layer of acellular
matrix. This may be caused by cytotoxicity of the implanted
alloplastic stents. All studied stents consisted of chromium-
nickel-ferrum (L-316) stainless steel (23).
In addition to SMCs, T lymphocytes and CD68-positive
cells infiltrate the neointima. This cellular immigration was
already described after experimental stenting in an animal
model (24,25). Accumulation of these reactive inflammatory
cells is limited to the stent zone and cannot be found in
proximal and distal vessel segments. Directly adjacent to the
alloplastic stent struts are inflammatory cells, usually aggre-
gated, and foreign body macrophages can be detected,
alluding to a possible immunologic cellular response to the
chromium-nickel alloy.
Neoendothelium. The response of the endothelium to
coronary stenting can be divided into three phases, as also
seen in animal studies. Up to 16 days after stenting complete
destruction of the endothelial cell layers, as an effect to the
implantation trauma after coronary stenting, can be found.
This severe endothelial alteration, as also seen after balloon
injury (26) and atherectomy (27,28), initiates the formation
of a thin, membranous thrombus covering the vascular and
stent surface. This thrombus functions as the endoluminal
layer of the vessel wall in the first weeks after stenting.
Up to 12 weeks after stent insertion only alpha-actin–
positive SMCs can be detected on the surface of the
generated neointima. Because of the endothelial denudation
in the initial phase of stent implantation, alpha-actin–
positive SMCs separate the vessel lumen and vessel wall.
Mature endothelial cells act not only as a physiologic barrier
against insudation into the vessel wall, but also as modula-
tors of vascular tonus (29) and regulators of SMC prolifer-
ation (30). In this way, missing mature endothelium in the
early incorporation phase and late reendothelialization may
act as a cofactor in the process of exaggerative SMC
proliferation.
Twenty-one days after balloon dilation of carotid arteries
of swine, reendothelialization was observed (31). Complete
endothelialization after experimental stenting in dogs was
found after eight weeks (32). In our study on human
coronary probes, mature endothelium (factor VIII–positive
cells of endothelial origin) completely covering the neoin-
tima was first documented 96 days after stenting.
Although different types of stents were analyzed in our
study, we found a uniform incorporation pattern in histo-
morphologic and immunohistochemical analysis. After im-
plantation of coil stents and tubular stents, identical cellular
and matrix compositions were found. Considering all im-
planted stents consisting of surgical L-316 stainless steel,
the documented inflammatory response may be a response
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to the implanted chromium-nickel alloy. Statistical analysis
of stent–neointima volume with regard to the implanted
stent design is not possible owing to the low case numbers
in this study. The tissue response after stenting of venous
aortocoronary bypasses does not differ from the incorpora-
tion process after stent implantation in coronary artery
stenoses (11).
We were not able to definitely identify the pathogenesis
of hyperproliferative neointima generation after stent inser-
tion in our pathologic-anatomic study. The significant
augmentation of inflammatory cells, especially of T lym-
phocytes, may preserve the stimulus to the hyperprolifera-
tive SMC response caused by the implantation trauma.
Whether the inflammatory response is only initiated by the
trauma of implantation—and perpetuated by the cytotoxic-
ity of the chromium-nickel material—must be studied in
further experiments. Accumulation of CD68-positive cells
(macrophages) is due to intramural neointimal and medial
hematoma. Spontaneous dissections can be observed even
months after the stenting procedure. As observed in cellular
cultures, activated macrophages produce platelet-derived
growth factor, which is one of the strongest mitogenic
stimuli on SMCs. Furthermore, the long period before
complete reendothelialization may be a cofactor causing
neointimal hyperplasia by SMC proliferation (33).
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